Phylogenetic analysis of bla (NDM) genes of carbapenem resistant uropathogens isolated from federal tertiary care hospital, Pakistan: insights into the evolution and dissemination of drug resistance

对巴基斯坦联邦三级医院分离的耐碳青霉烯类泌尿道病原体bla(NDM)基因进行系统发育分析:揭示耐药性的演变和传播

阅读:1

Abstract

BACKGROUND AND OBJECTIVES: Global health is seriously threatened by the rise of carbapenem-resistant Enterobacterales (CRE). The bla (NDM) gene, a key carbapenemase coding gene, causes global health concern due to its multidrug resistance and easy spread through mobile genetic elements. This study aimed to identify and genetically characterize the bla (NDM) genes from uropathogens, its antibiotic susceptibility, and its correlation with global sequences. MATERIALS AND METHODS: Urine samples were processed following microbiological guidelines. Isolates were identified using API-20E. Antibiotic susceptibility was tested using disc diffusion method, and bacterial DNAs were extracted for bla (NDM) gene sequencing for phylogenetic analysis. RESULTS: CREs were detected in 11.92% (n=51) of the 428 Enterobacterales. Among CRE isolates, 45% (n=23) were positive for bla (NDM) gene harbored by Klebsiella pneumoniae (57%), followed by Escherichia coli (26%). Uropathogenic CRE, harboring bla (NDM), revealed susceptibility of 34.78%, 60.87%, and 65.22% to amikacin, nitrofurantoin, and fosfomycin respectively. The bla (NDM-5) variant was most common (69.57%), followed by bla (NDM-1) (26.09%) and bla (NDM-7) (4.35%). Phylogenetic analysis revealed that bla (NDM) variants exhibit diverse relationships with Pakistani and worldwide sequences. CONCLUSION: The significant presence of bla (NDM) in uropathogens, along with extensive antibiotic resistance, underscores the urgent need for continuous monitoring and antibiotic stewardship programs to manage the growing threat of CRE infections.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。